Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes

Brain Research Bulletin

Volumn 80, Issue 4-5, 2009, Pages 274-281

  Beeler, Nicole ^a,b   Riederer, Beat M ^a,b   Waeber, Gérard ^a   Abderrahmani, Amar ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Alzheimer disease; IB1 JIP 1; Islets; JNK; Neuron; Type 2 diabetes

Indexed keywords

AMYLOID; ANTIDIABETIC AGENT; INSULIN SENSITIZING AGENT; ISLET BRAIN 1 PROTEIN; JNK INTERACTING PROTEIN 1; SCAFFOLD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEGENERATION; COGNITIVE DEFECT; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; NERVE DEGENERATION;

EID: 70349505965     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.07.006     Document Type: Article

References (129)

1. Abderrahmani A., Niederhauser G., Favre D., Abdelli S., Ferdaoussi M., Yang J.Y., Regazzi R., Widmann C., and Waeber G. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetologia 50 (2007) 1304-1314
2. Abderrahmani A., Niederhauser G., Plaisance V., Roehrich M.E., Lenain V., Coppola T., Regazzi R., and Waeber G. Complexin I regulates glucose-induced secretion in pancreatic {beta}-cells. J. Cell. Sci. 117 (2004) 2239-2247
3. Abderrahmani A., Steinmann M., Plaisance V., Niederhauser G., Haefliger J.A., Mooser V., Bonny C., Nicod P., and Waeber G. The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1). Mol. Cell. Biol. 21 (2001) 7256-7267
4. Ando K., Oishi M., Takeda S., Iijima K., Isohara T., Nairn A.C., Kirino Y., Greengard P., and Suzuki T. Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation. J. Neurosci. 19 (1999) 4421-4427
5. Atouf F., Czernichow P., and Scharfmann R. Expression of neuronal traits in pancreatic beta cells. Implication of neuron-restrictive silencing factor/repressor element silencing transcription factor, a neuron-restrictive silencer. J. Biol. Chem. 272 (1997) 1929-1934
6. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 (1994) 817-827
7. Bergem A.L., Engedal K., and Kringlen E. The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch. Gen. Psychiatry 54 (1997) 264-270
8. Bertram L., and Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 9 (2008) 768-778
9. Bonny C., Nicod P., and Waeber G. IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J. Biol. Chem. 273 (1998) 1843-1846
10. Bonny C., Oberson A., Negri S., Sauser C., and Schorderet D.F. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50 (2001) 77-82
11. Bonny C., Oberson A., Steinmann M., Schorderet D.F., Nicod P., and Waeber G. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J. Biol. Chem. 275 (2000) 16466-16472
12. Bonny C., Thompson N., Nicod P., and Waeber G. Pancreatic-specific expression of the glucose transporter type 2 gene: identification of cis-elements and islet-specific trans-acting factors. Mol. Endocrinol. 9 (1995) 1413-1426
13. Borsello T., Centeno C., Riederer I.M., Haefliger J.A., and Riederer B.M. Phosphorylation-dependent dimerization and subcellular localization of islet-brain 1/c-Jun N-terminal kinase-interacting protein 1. J. Neurosci. Res. 85 (2007) 3632-3641
14. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., Bogousslavsky J., and Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9 (2003) 1180-1186
15. Borsello T., Croquelois K., Hornung J.P., and Clarke P.G. N-methyl-d-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway. Eur. J. Neurosci. 18 (2003) 473-485
16. Bunck M.C., Diamant M., Corner A., Eliasson B., Malloy J.L., Shaginian R.M., Deng W., Kendall D.M., Taskinen M.R., Smith U., Yki-Jarvinen H., and Heine R.J. One-Year treatment with exenatide improves beta-cell function, compared to insulin glargine, in metformin treated type 2 diabetes patients: a randomized, controlled trial. Diabetes Care 32 (2009) 762-768
17. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., and Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
18. Centeno C., Repici M., Chatton J.Y., Riederer B.M., Bonny C., Nicod P., Price M., Clarke P.G., Papa S., Franzoso G., and Borsello T. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons. Cell Death Differ. 14 (2007) 240-253
19. Chang K.A., Kim H.S., Ha T.Y., Ha J.W., Shin K.Y., Jeong Y.H., Lee J.P., Park C.H., Kim S., Baik T.K., and Suh Y.H. Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 26 (2006) 4327-4338
20. Chen L., Liu L., Yin J., Luo Y., and Huang S. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int. J. Biochem. Cell Biol. 41 (2009) 1284-1295
21. Chen X., and Yan S.D. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease. IUBMB Life 58 (2006) 686-694
22. Cooper G.J., Willis A.C., Clark A., Turner R.C., Sim R.B., and Reid K.B. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 8628-8632
23. Craft S., Newcomer J., Kanne S., Dagogo-Jack S., Cryer P., Sheline Y., Luby J., Dagogo-Jack A., and Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging 17 (1996) 123-130
24. Cruts M., Hendriks L., and Van Broeckhoven C. The presenilin genes: a new gene family involved in Alzheimer disease pathology. Hum. Mol. Genet. 5 Spec No (1996) 1449-1455
25. Cullen P., von Eckardstein A., Souris S., Schulte H., and Assmann G. Dyslipidaemia and cardiovascular risk in diabetes. Diabetes Obes. Metab. 1 (1999) 189-198
26. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
27. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
28. Daw E.W., Payami H., Nemens E.J., Nochlin D., Bird T.D., Schellenberg G.D., and Wijsman E.M. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66 (2000) 196-204
29. Dias-Santagata D., Fulga T.A., Duttaroy A., and Feany M.B. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest. 117 (2007) 236-245
30. Dickens M., Rogers J.S., Cavanagh J., Raitano A., Xia Z., Halpern J.R., Greenberg M.E., Sawyers C.L., and Davis R.J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277 (1997) 693-696
31. Drewes G. MARKing tau for tangles and toxicity. Trends Biochem. Sci. 29 (2004) 548-555
32. Drucker D.J. The biology of incretin hormones. Cell Metab. 3 (2006) 153-165
33. Eisen A. Amyotrophic lateral sclerosis: a 40-year personal perspective. J. Clin. Neurosci. 16 (2009) 505-512
34. Ferdaoussi M., Abdelli S., Yang J.Y., Cornu M., Niederhauser G., Favre D., Widmann C., Regazzi R., Thorens B., Waeber G., and Abderrahmani A. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 57 (2008) 1205-1215
35. Gebre-Medhin S., Mulder H., Pekny M., Westermark G., Tornell J., Westermark P., Sundler F., Ahren B., and Betsholtz C. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem. Biophys. Res. Commun. 250 (1998) 271-277
36. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., and James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
37. Goedert M., Cuenda A., Craxton M., Jakes R., and Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16 (1997) 3563-3571
38. Ha H.Y., Cho I.H., Lee K.W., Lee K.W., Song J.Y., Kim K.S., Yu Y.M., Lee J.K., Song J.S., Yang S.D., Shin H.S., and Han P.L. The axon guidance defect of the telencephalic commissures of the JSAP1-deficient brain was partially rescued by the transgenic expression of JIP1. Dev. Biol. 277 (2005) 184-199
39. Haefliger J.A., Tawadros T., Meylan L., Gurun S.L., Roehrich M.E., Martin D., Thorens B., and Waeber G. The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic beta cells. J. Cell Sci. 116 (2003) 1463-1469
40. Hashimoto M., Hsu L.J., Rockenstein E., Takenouchi T., Mallory M., and Masliah E. alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277 (2002) 11465-11472
41. Helbecque N., Abderrahamani A., Meylan L., Riederer B., Mooser V., Miklossy J., Delplanque J., Boutin P., Nicod P., Haefliger J.A., Cottel D., Amouyel P., Froguel P., and Waeber G. Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease. Mol. Psychiatry 8 (2003) 413-422 363
42. Helbecque N., Cottel D., and Amouyel P. Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia. Neurobiol. Aging 30 (2009) 266-271
43. Holscher C. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Rev. Neurosci. 16 (2005) 181-212
44. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural. Transm. 105 (1998) 415-422
45. Hunot S., Vila M., Teismann P., Davis R.J., Hirsch E.C., Przedborski S., Rakic P., and Flavell R.A. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 665-670
46. Imarisio S., Carmichael J., Korolchuk V., Chen C.W., Saiki S., Rose C., Krishna G., Davies J.E., Ttofi E., Underwood B.R., and Rubinsztein D.C. Huntington's disease: from pathology and genetics to potential therapies. Biochem. J. 412 (2008) 191-209
47. Janson J., Laedtke T., Parisi J.E., O'Brien P., Petersen R.C., and Butler P.C. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53 (2004) 474-481
48. Janson J., Soeller W.C., Roche P.C., Nelson R.T., Torchia A.J., Kreutter D.K., and Butler P.C. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7283-7288
49. Jellinger K.A. Alzheimer 100-highlights in the history of Alzheimer research. J. Neural. Transm. 113 (2006) 1603-1623
50. Kadowaki H., Nishitoh H., Urano F., Sadamitsu C., Matsuzawa A., Takeda K., Masutani H., Yodoi J., Urano Y., Nagano T., and Ichijo H. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 12 (2005) 19-24
51. Kahn S.E., D'Alessio D.A., Schwartz M.W., Fujimoto W.Y., Ensinck J.W., Taborsky Jr. G.J., and Porte D. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39 (1990) 634-638
52. Kaneto H., Kawamori D., Matsuoka T.A., Kajimoto Y., and Yamasaki Y. Oxidative stress and pancreatic beta-cell dysfunction. Am. J. Ther. 12 (2005) 529-533
53. Kaneto H., Matsuoka T.A., Katakami N., Kawamori D., Miyatsuka T., Yoshiuchi K., Yasuda T., Sakamoto K., Yamasaki Y., and Matsuhisa M. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes. Curr. Mol. Med. 7 (2007) 674-686
54. Kaneto H., Matsuoka T.A., Nakatani Y., Kawamori D., Matsuhisa M., and Yamasaki Y. Oxidative stress and the JNK pathway in diabetes. Curr. Diabetes Rev. 1 (2005) 65-72
55. Kashyap S., Belfort R., Gastaldelli A., Pratipanawatr T., Berria R., Pratipanawatr W., Bajaj M., Mandarino L., DeFronzo R., and Cusi K.A. Sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52 (2003) 2461-2474
56. Kelkar N., Gupta S., Dickens M., and Davis R.J. Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol. Cell Biol. 20 (2000) 1030-1043
57. Kersten S., Desvergne B., and Wahli W. Roles of PPARs in health and disease. Nature 405 (2000) 421-424
58. Kim A.H., Yano H., Cho H., Meyer D., Monks B., Margolis B., Birnbaum M.J., and Chao M.V. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35 (2002) 697-709
59. Kloppel G., Lohr M., Habich K., Oberholzer M., and Heitz P.U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv. Synth. Pathol. Res. 4 (1985) 110-125
60. Kristensen O., Guenat S., Dar I., Allaman-Pillet N., Abderrahmani A., Ferdaoussi M., Roduit R., Maurer F., Beckmann J.S., Kastrup J.S., Gajhede M., and Bonny C. A unique set of SH3-SH3 interactions controls IB1 homodimerization. EMBO J. 25 (2006) 785-797
61. Lannfelt L. The genetics and pathophysiology of Alzheimer's disease. J. Intern. Med. 242 (1997) 281-284
62. Lee M.S., Kao S.C., Lemere C.A., Xia W., Tseng H.C., Zhou Y., Neve R., Ahlijanian M.K., and Tsai L.H. APP processing is regulated by cytoplasmic phosphorylation. J. Cell Biol. 163 (2003) 83-95
63. Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochem. Soc. Trans. 36 (2008) 343-347
64. Ling Z., Van de C.M., Dong J., Heimberg H., Haefliger J.A., Waeber G., Schuit F., and Pipeleers D. Variations in IB1/JIP1 expression regulate susceptibility of beta-cells to cytokine-induced apoptosis irrespective of C-Jun NH2-terminal kinase signaling. Diabetes 52 (2003) 2497-2502
65. Luchsinger J.A., Tang M.X., Shea S., and Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 63 (2004) 1187-1192
66. Lyras L., Cairns N.J., Jenner A., Jenner P., and Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68 (1997) 2061-2069
67. Maedler K., Schulthess F.T., Bielman C., Berney T., Bonny C., Prentki M., Donath M.Y., and Roduit R. Glucose and leptin induce apoptosis in human {beta}-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J. 22 (2008) 1905-1913
68. Magara F., Haefliger J.A., Thompson N., Riederer B., Welker E., Nicod P., and Waeber G. Increased vulnerability to kainic acid-induced epileptic seizures in mice underexpressing the scaffold protein Islet-Brain 1/JIP-1. Eur. J. Neurosci. 17 (2003) 2602-2610
69. Manning C.A., Ragozzino M.E., and Gold P.E. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol. Aging 14 (1993) 523-528
70. Martinez S.C., Tanabe K., Cras-Meneur C., Abumrad N.A., Bernal-Mizrachi E., and Permutt M.A. Inhibition of Foxo1 protects pancreatic islet (R)-cells against fatty acid and ER-stress induced apoptosis. Diabetes 55 (2008) 846-859
71. Mata M., Merritt S.E., Fan G., Yu G.G., and Holzman L.B. Characterization of dual leucine zipper-bearing kinase, a mixed lineage kinase present in synaptic terminals whose phosphorylation state is regulated by membrane depolarization via calcineurin. J. Biol. Chem. 271 (1996) 16888-16896
72. Matsuda S., Matsuda Y., and D'Adamio L. Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J. Biol. Chem. 278 (2003) 38601-38606
73. Migheli A., Piva R., Atzori C., Troost D., and Schiffer D. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 56 (1997) 1314-1322
74. J. Miklossy, H. Qing, A. Radenovic, A. Kis, B. Vileno, F. Laszlo, L. Miller, R.N. Martins, G. Waeber, V. Mooser, F. Bosman, K. Khalili, N. Darbinian-Sarlissian, P.L. McGeer, Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes, Neurobiol. Aging, in press, doi:10.1016/j.neurobiolaging.2008.08.019.
75. Mooney L.M., and Whitmarsh A.J. Docking interactions in the c-Jun N-terminal kinase pathway 1. J. Biol. Chem. 279 (2004) 11843-11852
76. Moulin N., and Widmann C. Islet-brain (IB)/JNK-interacting proteins (JIPs): future targets for the treatment of neurodegenerative diseases?. Curr. Neurovasc. Res. 1 (2004) 111-127
77. Munshi M., Grande L., Hayes M., Ayres D., Suhl E., Capelson R., Lin S., Milberg W., and Weinger K. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 29 (2006) 1794-1799
78. Murthy S.B., Jawaid A., and Schulz P.E. Diabetes mellitus and dementia: advocating an annual cognitive screening in patients with diabetes mellitus. J. Am. Geriatr. Soc. 56 (2008) 1976-1977
79. Nihalani D., Merritt S., and Holzman L.B. Identification of structural and functional domains in mixed lineage kinase dual leucine zipper-bearing kinase required for complex formation and stress-activated protein kinase activation. J. Biol. Chem. 275 (2000) 7273-7279
80. Nihalani D., Meyer D., Pajni S., and Holzman L.B. Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components. EMBO J. 20 (2001) 3447-3458
81. Nihalani D., Wong H., Verma R., and Holzman L.B. Src family kinases directly regulate JIP1 module dynamics and activation. Mol. Cell Biol. 27 (2007) 2431-2441
82. Nihalani D., Wong H.N., and Holzman L.B. Recruitment of JNK to JIP1 and JNK-dependent JIP1 phosphorylation regulates JNK module dynamics and activation. J. Biol. Chem. 278 (2003) 28694-28702
83. Nishimura E., Sasaki K., Maruyama K., Tsukada T., and Yamaguchi K. Decrease in neuron-restrictive silencer factor (NRSF) mRNA levels during differentiation of cultured neuroblastoma cells. Neurosci. Lett. 211 (1996) 101-104
84. Okajima F., Kurihara M., Ono C., Nakajima Y., Tanimura K., Sugihara H., Tatsuguchi A., Nakagawa K., Miyazawa T., and Oikawa S. Oxidized but not acetylated low-density lipoprotein reduces preproinsulin mRNA expression and secretion of insulin from HIT-T15 cells. Biochim. Biophys. Acta 1687 (2005) 173-180
85. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., and MBreteler M. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53 (1999) 1937-1942
86. Palm K., Belluardo N., Metsis M., and Timmusk T. Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene. J. Neurosci. 18 (1998) 1280-1296
87. Parton L.E., Ye C.P., Coppari R., Enriori P.J., Choi B., Zhang C.Y., Xu C., Vianna C.R., Balthasar N., Lee C.E., Elmquist J.K., Cowley M.A., and Lowell B.B. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449 (2007) 228-232
88. Pellet J.B., Haefliger J.A., Staple J.K., Widmann C., Welker E., Hirling H., Bonny C., Nicod P., Catsicas S., Waeber G., and Riederer B.M. Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain. Eur. J. Neurosci. 12 (2000) 621-632
89. Perrin V., Dufour N., Raoul C., Hassig R., Brouillet E., Aebischer P., Luthi- R., Carter N., and Deglon. Implication of the JNK pathway in a rat model of Huntington's disease. Exp. Neurol. 215 (2009) 191-200
90. Perry T., and Greig N.H. Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease. Curr. Alzheimer Res. 2 (2005) 377-385
91. Perry T., Lahiri D.K., Sambamurti K., Chen D., Mattson M.P., Egan J.M., and Greig N.H. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J. Neurosci. Res. 72 (2003) 603-612
92. Plaisance V., Niederhauser G., Azzouz F., Lenain V., Haefliger J.A., Waeber G., and Abderrahmani A. The repressor element silencing transcription factor (REST)-mediated transcriptional repression requires the inhibition of Sp1. J. Biol. Chem. 280 (2005) 401-407
93. Plaumann S., Blume R., Borchers S., Steinfelder H.J., Knepel W., and Oetjen E. Activation of the dual-leucine-zipper-bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A. Mol. Pharmacol. 73 (2008) 652-659
94. Porchet R., Probst A., Draberova E., Draber P., Riederer I.M., and Riederer B.M. Differential subcellular localization of phosphorylated neurofilament and tau proteins in degenerating neurons of the human entorhinal cortex. Neuroreport 14 (2003) 929-933
95. Pratico D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. N.Y. Acad. Sci. 1147 (2008) 70-78
96. Prentki M., and Nolan C.J. Islet beta cell failure in type 2 diabetes. J. Clin. Invest. 116 (2006) 1802-1812
97. Reynolds C.H., Betts J.C., Blackstock W.P., Nebreda A.R., and Anderton B.H. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74 (2000) 1587-1595
98. Riederer I.M., Herrero R.M., Leuba G., and Riederer B.M. Serial protein labeling with infrared maleimide dyes to identify cysteine modifications. J. Proteomics 71 (2008) 222-230
99. Risner M.E., Saunders A.M., Altman J.F., Ormandy G.C., Craft S., Foley I.M., Zvartau-Hind M.E., Hosford D.A., and Roses A.D. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 6 (2006) 246-254
100. Robertson R.P., Harmon J., Tran P.O., Tanaka Y., and Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52 (2003) 581-587
101. Rohrer L., Hersberger M., and von Eckardstein A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr. Opin. Lipidol. 15 (2004) 269-278
102. Sakuraba H., Mizukami H., Yagihashi N., Wada R., Hanyu C., and Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 45 (2002) 85-96
103. Savage M.J., Lin Y.G., Ciallella J.R., Flood D.G., and Scott R.W. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22 (2002) 3376-3385
104. Savioz A., Riederer B.M., Heutink P., Rizzu P., Tolnay M., Kovari E., Probst A., Riederer I.M., Bouras C., and Leuba G. Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21-22. Neurobiol. Dis. 12 (2003) 46-55
105. 2-terminal kinase. Hum. Mol. Genet. 16 (2007) 1862-1871
106. Schuit F.C., Huypens P., Heimberg H., and Pipeleers D.G. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 50 (2001) 1-11
107. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., and Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
108. Shimojo M., Paquette A.J., Anderson D.J., and Hersh L.B. Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST. Mol. Cell Biol. 19 (1999) 6788-6795
109. Shoji M., Iwakami N., Takeuchi S., Waragai M., Suzuki M., Kanazawa I., Lippa C.F., Ono S., and Okazawa H. JNK activation is associated with intracellular beta-amyloid accumulation. Brain Res. Mol. 85 (2000) 221-233
110. Sisodia S.S., and George-Hyslop P.H. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?. Nat. Rev. Neurosci. 3 (2002) 281-290
111. Sloane P.D., Zimmerman S., Suchindran C., Reed P., Wang L., Boustani M., and Sudha S. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu. Rev. Public Health 23 (2002) 213-231
112. Smith M.A., Rottkamp C.A., Nunomura A., Raina A.K., and Perry G. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502 (2000) 139-144
113. Standen C.L., Brownlees J., Grierson A.J., Kesavapany S., Lau K.F., McLoughlin D.M., and Miller C.C. Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3). J. Neurochem. 76 (2001) 316-320
114. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., and de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?. J. Alzheimers Dis. 7 (2005) 63-80
115. Subbarao K.V., Richardson J.S., and Ang L.C. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55 (1990) 342-345
116. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46 (2003) 733-749
117. Thakur A., Wang X., Siedlak S.L., Perry G., Smith M.A., and Zhu X. c-Jun phosphorylation in Alzheimer disease. J. Neurosci. Res. 85 (2007) 1668-1673
118. Thompson N.A., Haefliger J.A., Senn A., Tawadros T., Magara F., Ledermann B., Nicod P., and Waeber G. Islet-brain1/JNK-interacting protein-1 is required for early embryogenesis in mice. J. Biol. Chem. 276 (2001) 27745-27748
119. Toschi E., Camastra S., Sironi A.M., Masoni A., Gastaldelli A., Mari A., Ferrannini E., and Natali A. Effect of acute hyperglycemia on insulin secretion in humans. Diabetes 51 Suppl. 1 (2002) S130-S133
120. Verhey K.J., Meyer D., Deehan R., Blenis J., Schnapp B.J., Rapoport T.A., and Margolis B. Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J. Cell Biol. 152 (2001) 959-970
121. Waeber G., Delplanque J., Bonny C., Mooser V., Steinmann M., Widmann C., Maillard A., Miklossy J., Dina C., Hani E.H., Vionnet N., Nicod P., Boutin P., and Froguel P. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat. Genet. 24 (2000) 291-295
122. Waxman E.A., and Lynch D.R. N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11 (2005) 37-49
123. Whitmarsh A.J. The JIP family of MAPK scaffold proteins. Biochem. Soc. Trans. 34 (2006) 828-832
124. Whitmarsh A.J., Cavanagh J., Tournier C., Yasuda J., and Davis R.J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281 (1998) 1671-1674
125. Whitmarsh A.J., Kuan C.Y., Kennedy N.J., Kelkar N., Haydar T.F., Mordes J.P., Appel M., Rossini A.A., Jones S.N., Flavell R.A., Rakic P., and Davis R.J. Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev. 15 (2001) 2421-2432
126. Willoughby E.A., Perkins G.R., Collins M.K., and Whitmarsh A.J. The JNK-interacting protein-1 scaffold protein targets MAPK phosphatase-7 to dephosphorylate JNK. J. Biol. Chem. 278 (2003) 10731-10736
127. Xu W.L., Qiu C.X., Wahlin A., Winblad B., and Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63 (2004) 1181-1186
128. Yasuda J., Whitmarsh A.J., Cavanagh J., Sharma M., and Davis R.J. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell Biol. 19 (1999) 7245-7254
129. Zhao W.Q., Chen H., Quon M.J., and Alkon D.L. Insulin and the insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol. 490 (2004) 71-81